Brainstorm Cell Therapeutics Inc. (BCLI): Price and Financial Metrics
BCLI Price/Volume Stats
| Current price | $1.26 | 52-week high | $11.89 |
| Prev. close | $1.25 | 52-week low | $1.05 |
| Day low | $1.25 | Volume | 40,500 |
| Day high | $1.30 | Avg. volume | 58,633 |
| 50-day MA | $2.36 | Dividend yield | N/A |
| 200-day MA | $5.28 | Market Cap | 7.19M |
BCLI Stock Price Chart Interactive Chart >
Brainstorm Cell Therapeutics Inc. (BCLI) Company Bio
Brainstorm Cell Therapeutics Inc., a biotechnology company, develops adult stem cell therapies for neurodegenerative disorders. The company was founded in 2000 and is based in Hackensack, New Jersey.
BCLI Price Returns
| 1-mo | -40.57% |
| 3-mo | -75.06% |
| 6-mo | -84.37% |
| 1-year | -67.20% |
| 3-year | -97.01% |
| 5-year | -97.86% |
| YTD | -69.23% |
| 2023 | -83.35% |
| 2022 | -59.00% |
| 2021 | -11.60% |
| 2020 | 5.72% |
| 2019 | 20.56% |
Loading social stream, please wait...